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.AllSTRACT: Overpopulation of feral horses in several western states is an unquestioned problem. Current management strategies 
of removal and adoption are expensive, logistically challenging, and ineffective as a means of population control. We are testing 
three long-acting contraceptive approaches on feral Nevada mares. Modified reversible immunocontraceptive vaccines for 
gonadotropin releasing hormone (GnRH) and porcine zona pellucida (PZP) (SpayVac), and intrauterine contraceptive devices 
(IUDs), are being evaluated to determine: 1) their safety and efficacy for preventing pregnancy for multiple years, 2) whether the 
effects are reversible, and 3) whether there are notable contraindications. Preliminary data after 1 year suggest that IUD- and PZP-
treated mares continue to exhibit breeding and estrus, while GnRH-treated mares are less likely to cycle. All mares in the GnRH 
and PZP treatments were infertile for the breeding season. Eighty percent of the IUD-treated mares were infertile; those mares that 
became pregnant likely failed to retain the IUD. A notable contraindication was that uterine edema normally observed in mares in 
the follicular phase of the estrous cycle was commonly observed in PZP-treated mares. Because administration of each 
contraceptive approach is different, and each has different effects and expected duration, one approach or a combination of 
approaches may be best suited for specific field applications. Subsequent years of this study should establish the efficacy and safety 
of one or more long-acting contraceptive approaches for feral horse population control. 
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INTRODUCTION 
Ovexpopulation of feral horses in several western 
states is an unquestioned problem. In Nevada, feral 
horses under state control number about 1,200 in an area 
of 360,000 acres. This represents 2 - 2.Sx the nwnber of 
horses suitable for that area. Feral horse populations grow 
at a rate of 1 S - 20% a year while their range continues to 
s~ Current management strategies of removal and 
adoption are expensive, logistically challenging, and have 
not been an effective means of population control. Con-
flicting interests associated with increased movement of 
people into feral horse ranges, sympathy to maintain feral 
horse populations because of their historic and cultural 
importance, competition among horses and indigenous 
plant and wildlife species, as well as ranching interests are 
issues impacted by feral horse overpopulation. 
Reduction of free-ranging horse nwnbers by limiting 
fertility holds great promise for humane and effective 
population control. Ideally, contraception of feral horses 
should be sare and potentially reversible, effective for 
several years, and have minimaJ effect on repf9<fuctive or 
harem maintenance .behavior. However, fertility control 
by the porcine zona pellucida (PZP) vaccine in current use 
has not shown consistent effectiveness for more than 1 - 2 
years (fumer et al. 2002). Ann~ vaccination involves 
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much expense, manpower, and horse handling to maintain 
infertility and increases risks of injwy to both the animals 
and human handlers. Use of long-acting contraceptive 
approaches on feral horses would achieve effective 
population reduction along with reduced costs and risks 
associated with frequent animal handling. Unfortunately, 
no proven options exist for long-tenn contraception of 
horses. 
hnmunocontraceptive vaccines are based on the 
principle that an animal's immune system can be used to 
prevent reproduction. The immunogens of these vaccines 
stimulate antl"body production against native gamete 
proteins, reproductive hormones or proteins involved in 
early gestation. Vaccinated animals with sufficient titers 
form antibody-antigen complexes that interfere with or 
block an essential step in the reproductive process. 
The most widely used and successful zona pellucida 
vaccines are derived from. ovarian extracts of porcine 
zona pellucida (PZP). PZP is a complex of 4 large 
glycoproteins and is recognized as a foreign protein when 
·injected into a non-porcine host. Because there is 
considerable amino acid sequence conservation among 
species for the zona pellucida, the immune response in 
PZP-treated animals includes antibodies that cross-react 
with native zona pellucida. 
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Injectable PZP vaccines have been used widely to 
induce infertility in a variety of species including deer 
(fumer et al. 1997), elephants (Fayer-Hosken et al. 1999), 
dogs (Mahi-Brown et al. 1989), baboons (Dunbar 1989), 
seals (Brown et al. 1997), burros, and horses (Liu et al. 
1989, Kirkpatrick et al. 1996, Turner et al. 2002). 
Typically with a primary and booster vaccination, infertil-
ity can be achieved in 80-90% of animals for 1 year and 
further sustained by annual vaccination. Kirkpatrick, 
Turner, and colleagues have used the PZP vaccine effec-
tively to manage reproduction in selected feral horse 
populations by annual vaccination (fumer et al. 2002). 
Their pioneering work has documented the apparent 
safety and reversibility of the vaccine and some physio-
logical and behavioral responses of the mare (Kidq>atrick 
et al. 1996, Turner et al. 2002). These include repeated 
estrous cycles during the breeding season and improved 
body condition and increased longevity (Tuner and 
Kirkpatrick 2002). However, long-term treatment with 
PZP vaccine given annually is associated with some ow-
lation failure and depressed urinary estrogens (Kidq>atrick 
et al. 1995). 
Gonadotropin releasing hormone (GnRH) stimulates 
the anterior pituitary gland to produce and release FSH 
and Lii. These hormones in tum regulate gamete and 
hormone production by the gonads. By blocking GnRH, 
in either males or females, production of sex hormones 
and gametes ceases and treated animals enter a non-
breeding condition similat to that of anestrous in seasonal 
breeders. Use of GnRH vaccine as a fertility blocking 
agent has been studied in cattle (Adams and Adams 
1992), horses (Rabb et al. 1990), swine (Meloeri et al. 
1994), and rams (Brown et al. 1994). These studies have 
been of short duration, although. we recently completed a 
long-term study using the GnRH vaccine on white-tailed 
deer establishing its efficacy, safety, and reversibility 
(Miller et al. 2000). 
Extensive data for women have demonstrated that 
IUDs are safe and effective for long-term contraception 
(Fortney et al. 1999). According to ''Population Reports" 
(Vol. XXIll, #5, December 1995), in studies evaluating 
the copper-containing TCu-380A IUD, fewer than 1 in 
100 women became pregnant after 1 year, and 2.1 in 100 
women became pregnant after 10 years of continuous use. 
Fertility was restored following IUD removal. IUDs have 
also been shown to block fertility in ewes (Hawk et al. 
1974, French 1976), and cows and heifers (Hawk et al. 
1968, Turin et al. 1997, Fordyce et al. 2001) in short-term 
studies. The mechanism of IUD-induced infertility is 
speculative (Ortiz et al. 1996). Humoral factors may be 
released that interfere with signaling between the ovary 
and the uterus, blocking fertilization and early embryo 
development. We are aware of only one report of IUD 
use in mares (Daels and Hugh.es 1995). Six mares 
implanted with a silastic ring IUD remained infertile for a 
season, but after IUD removal all had foals the next 
season. Mild chronic endometritis was observed in the 
treated mares, but no permanent changes in the 
endometrium remained after IUD removal. 
Based on published studies and ongoing studies we 
have with deer, swine, and ponies, we believe that 3 long-
acting contraceptive approaches warrant study in feral 
horses. These are the SpayVac PZP vaccine, a GnRH 
vaccine developed at the National Wildlife Research 
Center, and the 380 Copper 'T' human intrauterine 
device. 
The objectives of this study are to evaluate these 
approaches in Nevada mares for multipl~year contra-
ceptive efficacy, whether the contraceptive effects are 
reversible, and whether notable contraindications are as-
sociated with the treatments. This paper reports the 
results from the first year of the study. 
MA~ANDMETBODS 
Animals 
The Nevada Department of Agriculture provided 53 
feral mares and 3 stallions for the project. The horses 
were gathered from state lands and maintained at the State 
of Nevada Penitentiary, Carson City filcility. Mares and 
stallions were dewormed 3x and vaccinated annually for 
eastern and western encephalitis, West Nile virus, infl.u-
ema, equine rhinopneum.onitis, and tetanus. Nevada 
mares typically weigh betwem 225-360 kg. 
To handle feral mares for jugular blood sampling and 
vaccinations, they were nm into a hydraulic chute and 
haltered. Contraceptive vaccines were given intramuscu-
larly in the left lateral neck. For pregnancy evaluations by 
ultrasound or palpation, or IUD placement, the mares 
were chemically restrained, released ftom the chute, and 
legs secured. Chemical restraint providing 20 - 30 min-
utes of anesthesia involved one or a combination of 
sedative and anesthetic agents. Initially, a combination of 
detomidine hydrochloride (0.02 - 0.04 mglkg) and xyla-
zine hydrochloride 0.8 mg/kg and acepromazine maleate 
(0.02 - 0.04 mglkg) was given intravenously. After 5 - 7 
minutes to allow for maximum sedation, mares were then 
given intravenously a combination of xylazine hydro-
chloride (1.2 mglkg) and tiletamine HCL (lmglkg) and 
zolazepam HCL (lmglkg). 
Treatments 
Mares were randomly asmgned to the following 
groups: untreated controls (n = 8), single shot of 400µg 
SpayVac PZP (n = 12), single-shot l,800µg GnRH vac-
cine (n = 15), 2,800µg GnRH vaccine (n = 3), and copper-
containing IUDs (n = 15). Doses of the single-shot 
SpayVac PZP vaccine (400µg) were kindly provided by 
its developer, Dr. Robert Brown (Brown et al. 1997). The 
single shot GnRH-AdjuVac vaccine was developed at and 
provided by the NWRC. Both vaccines were used in 
combination with AdjuVac adjuvant (Miller et al. 2003). 
Human Cu 380 T intrautaine devices were purchased 
ftom Family Planning Sales Limited, Littlemore, Oxford, 
UK. 
Because of the logistics of acquiring all of the mares 
for this study, the treatments were administered over a 
period of one year as the mares became available. The 
treatments were selected based on preliminary studies and 
our prior experience with them. We have determined that 
the single shot PZP (SpayVac) vaccine used in this study 
is very effective for cont:raception of white-tailed deer for 
4 years, while others have reported long-term contracep-
tion of fiill.ow deer (Fraker et al. 2002). We have also 
determined the GnRH vaccine to be effective in deer and 
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swine for 2 to 3 years in ongoing studies. In prelim.inmy 
studies at Peon State University, we evaluated 3 different 
copper IUDs in pony mares. Based upon ease of 
placement, retention in the uterus, lack of apparent uterine 
inflammatory response, and pregnancy prevention (3 of 4 
mares) for 24 months, the human copper 'T' run was 
selected for this trial. 
Nevada mares were routinely observed for breeding 
activity by staff and prisoner caretakers, and they were 
checked 2 times yearly by ultrasonographic monitoring 
for pregnancy, run retention and uterine inflammation, 
and blood sampled. Blood samples were assayed for 
estradiol, progesterone, and anttbody titers to the contra-
ceptive vaccines. Contraindications evaluated included 
gene.ml health and body condition, and uterine edema, 
which may be associated with hormonal changes or 
pn::scnce of IUDs. 
RESULTS AND DISCUSSION 
Most Nevada wild horses maintained at the Carson 
City filcility were posstble to work with and collect data. 
However, on some dates we were unable to collect data 
from certain individuals, because of inadequate anesthesia 
and/or safety concerns. 
After one breeding season involving study mares 
being with a proven stallion for at least 60 days, none of 
the mares in the PZP-SpayVac (0/12 mares) or GnRH 
(0/18) vaccine groups were pregnant as evaluated by 
ultrasonography (Figure 1 ). For the run mares, 20% 
became pregnant (3/15). This compares with 75% of the 
control mares (6/8) becoming pregnant These results 
clearly indicate that both contraceptive vaccines were 
highly effective in preventing pregnancy. Although 
somewhat less effective, the run treatment was also 
considered successful in preventing pregnancy in a high 
percentage of mares. Based on our inability to observe 
the run in pregnant mares, a tentative conclusion is that 
the pregnant individuals in the run treatment failed to 
retain their runs. This may have occurred because the 
human 380 copper 'T' used in this study is quite small 
(about l" long) and may have been more easily expelled 
from the mare uterus than the human uterus for which it 
was designed. We are currently testing larger copper-
containing runs to determine if retention is improved. 
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Figure 1. Percentage of mares not pregnant for each 
treatment group, based on ultrasonography. 
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Figure 2. Relative antibody titers of lndlvldual mares (# 
1·12) generated In respon1e to the 400µg SpayVac-PZP 
vaccine, 7 months poet-Immunization. 
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Figure 3a. Antibody titers of Individual mares (#1·9) 
generated In respon1e to the 1800µg GnRH vaccine, 7 
months post-Immunization. 
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Figure 3b. Antibody titers of Individual mares (#1-4) 
generated In response to the 2800µg GnRH vaccine, 7 
months post-Immunization. 
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Individual antibody titers for the SpayVac-PZP 
vaccine indicate a wide range of titers among individuals 
receiving the single 400µg dose (Figure 2). Seven of the 
individuals had titers one-third or less than the S mares 
with the highest titers. Nevertheless, all of the titers were 
adequate to impart contraception for the breeding season. 
For the GnRH mares receiving the l ,800µg dose, a range 
of titer responses was also evident (Figure 3a) but 
somewhat less diverse than that seen for the PZP mares 
(Figure 2.) The three mares receiving the 2,800µg did not 
produce titers that were greater than mares receiving the 
lower dose (Figure 3b), and all GnRH vaccine-treated 
mares were infertile. Future years of study on all 
vaccinated mares may provide evidence that higher titers 
are associated with a longer lasting contraceptive effect, 
but for now this remains speculative. 
180 
160 
=- 140 E 120 
-QI 
ca. 
-
100 
0 80 
~ 60 • ..
- 40 ., w 
20 
0 
PZP GnRH IUD 
Figure 4a. Serum estradlol concentrations determined In 
November 2003 when mares were evaluated by 
ultrasonography for pregnancy. 
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Figure 4b. Serum progesterone concentrations 
determined In November 2003 when mares were 
evaluated by ultrasonography for pregnancy. 
An intriguing aspect of this study is related to the 
average estradiol (Figure 4a) and progesterone (Figure 
4b) serum concentrations determined for each of the 
treatment groups. Average values determined from a 
single sampling of a population can provide some 
insights into whether animals within the population are 
experiencing estrous cycles. The typical mare estrous 
cycle is 22 days long (Ginther 1992). During 4 - 6 days 
of the cycle mares are in the follicular phase, during 
which estrogen secretions associated with follicular 
development increase and behavioral estrus occurs. 
During the remaining 16 - 18 days of the cycle, proges-
terone secretions are predominant. Therefore, for a 
randomly-sampled population of cycliQg mares, one 
would predict serum progesterone to be elevated and 
estradiol to be lower in 75 - 80% of the mares. How-
ever, for the PZP-treated mares, average serum 
estrogen was elevated in the majority of mares (Figure 
4a) and serum progesterone was negligible (Figure 4b). 
These observations suggest that PZP-treated mares may 
not cycle normally and may fail to develop a func-
tional, progesterone-secreting corpus luteum. An alter-
native explanation may be that the estrous cycles of the 
mares in the PZP group were synchronized and in 
estrus at the time of sampling, although there are no 
data to support this conclusion. In contrast to the PZP-
treated mares, GnRH-treated mares had low serum 
concentrations of both estrogen and progesterone (Fig-
ure 4a and 4b), which is in accord with the predicted 
effect of the vaccine to immunologically castrate 
treated individuals (Miller et al. 2003) . 
Mares with RJDs had elevated average serum 
progesterone and somewhat elevated serum estrogen 
(Figure 4a and 4b.), suggesting that the majority of mares 
within the run treatment are cycling. Unfortunately, we 
do not have average serum estrogen and progesterone 
concentrations for a group of control mares that were 
cycling and not pregnant to use for comparison. Seventy-
five percent of the control mares in this study were 
pregnant 
There was no indication of adverse treatment effects 
on body condition and general health of the mares on the 
study. Ultrasonography of the uterus did not reveal 
evidence of uterine infection or fluid accumulation 
associated with the presence of the run. Uterine edema, 
typical of mares in estrus, was evident in ultrasonograms 
(fable 1 ). For cycling mares in a typical population, we 
would predict that -25% of the females to be in the 
follicular phase based on an average cycle length of 22 
days, and 4 - 6 of those days in the follicular phase. It is 
notable that we observed uterine edema in -25% the 
mares in the run and GnRH treatments, as predicted. 
However, 82% of the PZP-treated mares showed evidence 
of uterine edema (fable 1). These findings support the 
serum steroid observations showing estrogen as the 
dominant serum hormone in PZP-treated mares (Figure 
4a). 
In conclusion, results of the first year of study 
indicated that both vaccines and the run contraceptive 
approaches are successful in preventing pregnancy in a 
high percentage of mares. Establishing the long-term effi-
cacy and potential contraindications of these approaches, 
to be determined in future years of study, will be critical 
to establishing the utility of these approaches for popula-
tion control of wild horses. 
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